{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:54:47Z","timestamp":1784548487942,"version":"3.55.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jdcr.2019.03.015","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T05:37:03Z","timestamp":1556516223000},"page":"427-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Regional vitiligo induced by imiquimod treatment for in-transit melanoma metastases"],"prefix":"10.1016","volume":"5","author":[{"given":"Elizabeth","family":"Tkachenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca I.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdcr.2019.03.015_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5021\/ad.2018.30.4.454","article-title":"Development of Vitiligo-like depigmentation after treatment of lentigo maligna melanoma with 5% imiquimod cream","volume":"30","author":"Kim","year":"2018","journal-title":"Ann Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2019.03.015_bib2","doi-asserted-by":"crossref","first-page":"e1419113","DOI":"10.1080\/2162402X.2017.1419113","article-title":"Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial","volume":"7","author":"Teulings","year":"2018","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.jdcr.2019.03.015_bib3","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1468-3083.2006.01533.x","article-title":"Imiquimod-induced vitiligo in a patient with genital warts [14]","volume":"20","author":"Stefanaki","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jdcr.2019.03.015_bib4","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/j.1524-4725.2012.02512.x","article-title":"Imiquimod-induced depigmentation: report of two cases and review of the literature","volume":"38","author":"Burnett","year":"2012","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jdcr.2019.03.015_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/jid.2011.247","article-title":"Immunomodulation by imiquimod in patients with high-risk primary melanoma","volume":"132","author":"Narayan","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"issue":"7","key":"10.1016\/j.jdcr.2019.03.015_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2014.57.4756","article-title":"Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis","volume":"33","author":"Teulings","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jdcr.2019.03.015_bib7","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.0803826","article-title":"Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy","volume":"182","author":"Broomfield","year":"2009","journal-title":"J\u00a0Immunol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619301183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619301183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:20:26Z","timestamp":1762474826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512619301183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2352512619301183"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.03.015","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional vitiligo induced by imiquimod treatment for in-transit melanoma metastases","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}